# BioCardia, Inc.: Form 8-K, filed Apr 2, 2026

- Company: [BioCardia, Inc.](/companies/bcda.md) (CIK 925741)
- Form: 8-K
- Filed: 2026-04-02
- Accepted by EDGAR: Apr 2, 2026, 13:00 ET
- Period: 2026-04-02
- Accession: 0001437749-26-010967
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/925741/000143774926010967/bcda20260402_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/925741/000143774926010967/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/925741/000143774926010967/bcda20260402_8k.htm

Filed Apr 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-010967. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.